Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FXKGL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,161
Award facts
- Contract value 100% obligated
- $19,160.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,160.91 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation under a firm fixed price contract. This award was made without a set-aside designation on September 2, 2025, with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The delivery order represents a single transaction within the company's broader pharmaceutical supply relationship with the Defense Logistics Agency.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The award of this delivery order for Cosentyx, an immunosuppressant medication used to treat conditions such as psoriasis and rheumatoid arthritis, reflects the Defense Logistics Agency's ongoing utilization of AmerisourceBergen's pharmaceutical distribution capabilities to meet military medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FXKGL?
SPE2DB25FXKGL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FXKGL worth?
The government has obligated $19,161 on SPE2DB25FXKGL.
Is contract SPE2DB25FXKGL an order under another contract?
Yes. SPE2DB25FXKGL is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXKGL competed?
The extent of competition for SPE2DB25FXKGL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award